Welcome to our dedicated page for Prestige Consumer Healthcare SEC filings (Ticker: PBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Prestige Consumer Healthcare's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Prestige Consumer Healthcare's regulatory disclosures and financial reporting.
Schedule 13G/A disclosure by Ariel Investments, LLC reports beneficial ownership of 2,202,327 shares of Prestige Consumer Healthcare common stock, representing 4.5% of the class. Ariel states it has sole voting power over 1,950,287 shares and sole dispositive power over 2,202,327 shares. The filing certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Ariel notes its adviser clients have rights to dividends or sale proceeds on these securities and that no client has an economic interest exceeding 5%.